Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

35results about How to "Strict medication" patented technology

Medicament for treating colonitis

The invention discloses a medicament for treating colonitis, which is prepared from the following bulk drugs by weight: 200 portions of calcite (calcined), 40 portions of halitum (calcined), 400 portions of clematis aethusifolia (calcined), 400 portions of rhododendron micranthum (calcined), 5 portions of nutmeg, 5 portions of coriander fruit, 5 portions of rhizoma zingiberis, 5 portions of long pepper, 5 portions of dwarf lilyturf root, 1 portion of pepper, 5 portions of dried white turnip, 5 portions of sal ammoniac, 5 portions of purple sal ammoniac, 5 portions of elecampane, and 10 portions of potassium nitrate. The formulation is a pure Chinese medicament preparation, has small toxic side effect, is suitable for the characteristic of chronic colonitis recurrent attacks, can be taken for a long time, and has remarkable curative effect; besides the formulation adopts a dosage form of enteric-coated granules to avoid the first pass effect in stomach absorption and act on affected parts directly, and each medicinal material in the formulation adopts the principle of relieving diarrhea with astringents and treating both principal and secondary aspects of a disease to achieve the aim of treatment, thus the medicament for treating colonitis is surely a classic anaesthetic worthy of development in clinical application.
Owner:INNER MONGOLIA TIANQI HAN&MONGOLIA PHARMA CO

Chinese medicinal compound for treating coronary heart diseases, preparation method and application thereof

The invention discloses a Chinese medicinal compound for treating coronary heart diseases, a preparation method and application thereof. The Chinese medicinal compound consists of the following raw materials in part by weight: 6 to 60 parts of dwarf lilyturf tuber, 3 to 15 parts of common macrocarpium fruit, 3 to 20 parts of leech, 6 to 60 parts of rhodiola rosea, 6 to 60 parts of ginkgo leaf and 6 to 60 parts of giant knotweed rhizome. The Chinese medicinal compound provided by the invention is prepared in proportion by adopting the theory of syndrome differentiation and treatment according to the theory of the traditional Chinese medical science, pharmacological experimental results indicate that the Chinese medicinal compound provided by the invention has the excellent effects of nourishing heart and kidney, clearing heat and invigorating blood circulation and eliminating blood stasis and removing obstruction in channels, and the modern pharmacological study indicates that the Chinese medicinal compound has the strong effects of improving myocardial oxygen-carrying capacity, expanding the coronary artery, anticoagulating, resisting inflammation, reducing lipid and the like, so the Chinese medicinal compound can resist myocardial ischemia, relieve angina of the coronary heart diseases, resist arteriosclerosis and prevent thrombosis; and the Chinese medicinal compound provided by the invention has low adverse reactions and can be used for treating the coronary heart diseases.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Traditional Chinese medicine combinatorial composition for treatment of double-flexure syndrome and preparation method and applications thereof

The invention discloses a traditional Chinese medicine combinatorial composition for the treatment of double-flexure syndrome, and the traditional Chinese medicine combinatorial composition is prepared from codonopsis pilosula, rhizoma atractylodis macrocephalae, folia perillae acutae, ginger processed pinellia, perilla stems, pericarpium citri reticulatae viride, lindera aggregate, raw rhubarb, wine-fried rhubarb, paeonia suffruticosa, fried peach kernels, fried fatmelon kernels, fructus aurantii immaturus, fructus aurantii, rhizoma curcumae, herba patriniae, dandelion, mirabilite, rhizoma corydalis, szechwan Chinaberry fruits, cortex magnoliae officinalis, fried snakegourd seeds, medicated leaven, fructus hordei germinatus, radix curcumae, rhizoma cimicifugae, cassia twig, radix paeoniae alba, ethyl acetate extracts of koraiensis barks, angelica sinensis, radix rehmanniae praeparata and dates, n-hexane extracts of cinnamon, pepper, wild pepper and fennel fruits, and glycerol extracts of mint and smilax glabra. The composition disclosed by the invention is scientific and reasonable in TCM (traditional Chinese medicine) formula, has the effects of soothing liver, regulating qi, regulating the flow of qi in intestines, promoting the circulation of qi, enriching the blood and moisturizing the intestine, strengthening spleen, dissolving turbidity, eliminating phlegm, eliminating stagnation, tonifying gallbladder and dispersing accumulations, has a good treatment effect on double-flexure syndrome; and by using the composition, patients which can not be subjected to operative treatment need not to suffer from the sequelae of operative treatment, therefore, the operative resection rate of colons is reduced, and the life quality of patients can be significantly improved.
Owner:HEILONGJIANG UNIV OF CHINESE MEDICINE

Traditional Chinese medicine composition with effect of treating metabolic syndrome and preparation method and application of traditional Chinese medicine composition

ActiveCN108066650AThe proportion of traditional Chinese medicine compound is scientific and reasonableStrict medicationMetabolism disorderEndocrine system disorderLipid Metabolism DisorderHoneysuckle
The invention discloses a traditional Chinese medicine composition with effect of treating metabolic syndrome and a preparation method and application of the traditional Chinese medicine composition.The traditional Chinese medicine composition with effect of treating metabolic syndrome is prepared from the following components in parts by weight: 15-45 parts of Radix Pseudostellariae, 15-45 partsof Radix Ophiopogonis, 10-30 parts of Radix Salviae Miltiorrhizae, 10-30 parts of Flos Sophorae Immaturus, 10-30 parts of Flos Chrysanthemi, 10-30 parts of Flos Lonicerae, 10-30 parts of Rhizoma Imperatae and 10-30 parts of Semen Raphani. Proportioning of the formula is implemented by a theory of treatment based on syndrome differentiation, a clinical experiment result shows that the traditionalChinese medicine composition has combined actions of multiple links and multiple targets, can correct glucose and lipid metabolism disorder of patients with the metabolic syndrome, has effects of reducing blood glucose, blood fat and blood pressure, and improving insulin resistance, and can be used for preventing and treating the metabolic syndrome, and the clinical experiment result shows that the traditional Chinese medicine composition does not have adverse reactions when orally taken for a long time, and is safe to use.
Owner:JIANGSU PROVINCIAL HOSPITAL OF TCM +1

Traditional Chinese medicine acupoint application formula for abdominal obesity as well as preparation method and application of traditional Chinese medicine acupoint application formula

The invention discloses a traditional Chinese medicine acupoint application formula for abdominal obesity as well as a preparation method and application of the traditional Chinese medicine acupoint application formula. The traditional Chinese medicine acupoint application formula is characterized by comprising the following components in parts by weight: 18-22 parts of rhizoma coptidis, 18-22 parts of radix et rhizoma rhei, 18-22 parts of radix scutellariae, 18-22 parts of cortex phellodendri, 18-22 parts of poria cocos, 18-22 parts of fructus aurantii immaturus, 18-22 parts of myrrh, 15-18 parts of radix phytolaccae and 8-12 parts of radix glycyrrhizae. The medicine disclosed by the invention has effects of promoting QI circulation, tonifying the spleen, clearing heat, promoting diuresis, dissolving turbidity and the like, and the traditional Chinese medicine acupoint application prepared from the medicine has a good curative effect on abdominal obesity. The medicine has an obvious effect after being applied to the acupoint for 7-14 days. Clinical observation shows that the effect is better when the acupoint application time is prolonged.
Owner:殷杰

Traditional Chinese medicine composition for treating breast tumor

The invention relates to a traditional Chinese medicine composition for treating breast tumor. The traditional Chinese medicine composition comprises the following ingredients in parts by weight: 120 to 150 parts of paris polyphylla, 120 to 150 parts of iphigenia indica, 200 to 220 parts of house lizard, 100 to 120 parts of toad skin, 10 to 15 parts of venenum bufonis, 50 to 65 parts of airpotato yam and 35 to 50 parts of panax notoginseng in the first group; 450 to 520 parts of selfheal, 450 to 520 parts of oldenlandia diffusa, 200 to 250 parts of nidus vespae, 300 to 320 parts of sculellaria barbata, 200 to 225 parts of chinaroot greenbrier, 220 to 250 parts of ranunculus ternatus thunb, 250 to 270 parts of rhodiola rosea, 150 to 170 parts of rhizoma sparganii, 220 to 250 parts of ramulus euonymi, 100 to 150 parts of rhizoma zedoariae, 120 to 150 parts of air potato, 300 to 350 parts of leonurus japonicus, 220 to 250 parts of rabdosia rubescens and 200 to 250 parts of rhizoma bolbostemmae in the second group. The traditional Chinese medicine composition has the advantages that natural traditional Chinese medicine raw materials are used; the medicine sources are wide; the cost is low; the preparation is simple; the toxic and side effects are few; the curative effect is obvious.
Owner:薛振宇

Traditional Chinese medicine composition capable of resisting breast cancer activity and preparation method and application thereof

The invention discloses a traditional Chinese medicine composition capable of resisting breast cancer activity and a preparation method and an application thereof. The traditional Chinese medicine composition is prepared by 15 to 45 parts of uniflower swisscentaury root, 15 to 45 parts of muskroot-like semiaquilegia root, 6 to 18 parts of vinegar processing radix bupleuri, 10 to 30 parts of asparagus fern, 15 to 45 parts of ajuga decumbens thunb, and 10 to 30 parts of fiveleaf akebia fruit. After proofing by pharmacological experiments, the traditional Chinese medicine composition capable of resisting the breast cancer activity has the advantages that the usage of the medicine is strict, the proportion is scientific and reasonable, and the effects of resisting cancers and detoxifying, dissipating phlegm and removing blood stasis, benefiting qi and nourishing yin and the like are realized; the strong killing function on the breast cancer inside and outside the human body is realized; the immunity of a tumor patient is improved, and the survival quality is improved; the safety is high, and the toxic and side effect is low. The preparation method has the advantages that the quality is stable, the content of extracted effective ingredients is high, the operability is high, and the preparation method is suitable for industrial and large-batch production.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

A Chinese medicinal composition for treating pneumoconiosis and pulmonary fibrosis, and its preparation method

The invention discloses a Chinese medicinal compound composition for treating pneumoconiosis and pulmonary fibrosis and a preparation method thereof. The Chinese medicinal compound composition is prepared from 8-30 parts of rhodiola root, 1-4 parts of vine cyanine extract, 2-6 parts of cordyceps, 1-4 parts of ganoderma lucidum, 1-4 parts of strawberry (oriental), 5-20 parts of fritillary bulb, 3-10 parts of saussurea involucrata, 1-4 parts of radix asteris, 3-10 parts of ophiopogon and 1-4 parts of radix arnebiae. The results show that, the Chinese medicinal composition for treating pneumoconiosis and pulmonary fibrosis, Strict medication, scientific and reasonable proportion, has the functions of replenishing lung qi, improving immune function, resolving phlegm, relieving cough and asthma, improving lung ventilation function, and has a strong effect on tracheitis, obstructive emphysema, pneumoconiosis and other respiratory system, and high safety, low toxicity and side effects. At thesame time, the preparation method provided by the invention has the advantages of stable quality, high content of extracted effective ingredients, strong operability, and is suitable for large-scaleindustrial production.
Owner:LIUYANG LIMEI IMMUNITY REHABILITATION CENT CO LTD

A traditional Chinese medicine compound composition for treating neurogenic bladder disease and its preparation method and application

InactiveCN104940721BGood treatment effectGood for promoting urinationNervous disorderAnthropod material medical ingredientsDiseaseResidual urine volume
The invention discloses a traditional Chinese medicinal compound composition for treating neurogenic bladder disorders. The composition is prepared from the following materials: 10 to 30 parts of coix seeds, 10 to 30 parts of scrophularia ningpoensis, 10 to 30 parts of astragalus membranaceus, 10 to 30 parts of atractylodes macrocephala, 10 to 30 parts of cornus officinalis, 10 to 30 parts of mantis egg case, 10 to 30 parts of rhizoma acori graminei, 2 to 10 parts of manis pentadactyla, 5 to 15 parts of alisma plantago-aquatica, 5 to 25 parts of semen plantaginis, 10 to 30 parts of rhizoma dioscoreae colletii, 10 to 30 parts of dried pyrrosia lingua leaves, 10 to 30 parts of tetrapanax papyriferus, 10 to 30 parts of lysimachia christinae hance, 10 to 30 parts of radix stephaniae tetrandrae, 10 to 30 parts of dried laminaria sporophytes, 10 to 25 parts of dried pyrrosia lingua leaves and 10 to 30 parts of gardenia jasminoides. According to the invention, the raw material compatibility prescription is selected based on traditional Chinese medical theory, and the compatibility of all components is scientific and reasonable; experimental results show that the traditional Chinese medicinal compound composition can effectively improve urinary tract symptoms and urodynamic related indicators, effectively restore the lower urinary tract function and reduce the bladder residual urine volume, and has a good curative effect on neurogenic bladder disorders.
Owner:哈尔滨医科大学附属第四医院

Traditional Chinese medicine compound composition capable of treating hypertensive patients with diabetes as well as preparation method and application thereof

The invention discloses a traditional Chinese medicine compound composition capable of treating hypertensive patients with diabetes as well as a preparation method and application thereof. The traditional Chinese medicine compound composition is prepared from 15-45 parts of codonopsis pilosula, 15-45 parts of rehmannia root, 10-30 parts of danshen root, 10-30 parts of sophora flower bud, 10-30 parts of common lophatherum herb, 10-30 parts of reed rhizome, 10-30 parts of kudzuvine root, and 10-30 parts of perilla seed. The traditional Chinese medicine compound composition provided by the invention adopts a theory of treatment according to syndrome differentiation to have a prescription, and clinical experimental results show that the traditional Chinese medicine compound composition provided by the invention has comprehensive effects of multiple links and multiple targets, can improve clinical symptoms of hypertensive patients with diabetes, has the effects of lowering blood pressure and blood sugar and improving insulin resistance, and can be used for preventing and treating the hypertensive patients with diabetes; and the clinical experimental results show that the traditional Chinese medicine compound provided by the invention has no adverse reaction after long-term use and is safer to use.
Owner:严士海

A kind of traditional Chinese medicine preparation with antitumor effect

The invention discloses a traditional Chinese medicine preparation with an antitumor effect. The traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 20-80 parts of oldenlandia diffusa, 20-60 parts of sculellaria barbata, 1-10 parts of radix aconiti preparata, 10-60 parts of girald daphne bark, 1-10 parts of venenum bufonis, 20-60 parts of edible tulip, 20-40 parts of salviae miltiorrhizae, 20-40 parts of sophora flower bud, 10-40 parts of lucid ganoderma, 10-50 parts of polygonatum kingianum, 10-40 parts of gorgon fruits, 10-40 parts of poria cocos, 20-60 parts of Chinese yam, 10-30 parts of radix sophorae flavescentis, 10-40 parts of rhizoma dioscoreae nipponicae, 10-45 parts of radix achyranthis bidentatae and 20-60 parts of acanthopanax roots. According to the traditional Chinese medicine preparation disclosed by the invention, traditional Chinese medicines are matched and combined into a formula based on the treatment theory in the syndrome differentiation according to the traditional Chinese medicine theory; medication is rigorous and scientific; an experiment result proves that the traditional Chinese medicine preparation has good effects of inhibiting tumor cell growth and prompting tumor cell apoptosis, has a relatively high killing effect on a plurality of tumor cells, and has the effects of strengthening the body resistance, culturing the source and prompting immunologic functions.
Owner:HEILONGJIANG UNIV OF CHINESE MEDICINE

Anti-tumor Chinese medicine and preparation method and application thereof

The invention relates to an anti-tumor Chinese medicine and a preparation method and application thereof, and belongs to the field of Chinese medicines. The Chinese medicine comprises, by weight, 25-35 parts of smooth stylose staff-tree, 15-25 parts of flea bodies, 10-20 parts of brooklet anemine root, 15-25 parts of selfheal and 15-25 parts of dandelion. The anti-tumor Chinese medicine has a goodeffect of inhibiting the growth of breast cancer cell and promoting the apoptosis of the breast cancer cell. The curative effect is accurate and reliable. The inhibition rate to human breast cancer cell (MCF-7) in nude mice is 75%, the inhibition rate to human breast cancer cell (MCF-7) is equal or greater than 67%, and inhibition rate to the Lewis tumor cell line tumor is 60%. The pain of tumorpatients is reduced, and the survival time is proloned, and it is showed that the anti-tumor Chinese medicine has high safety, low toxicity and side effects, and the effect is better than other anti-tumor traditional Chinese medicine compositions by the long-term experimental study. The anti-tumor Chinese medicine can be conveniently prepared into a variety of dosage form with pharmaceutical carriers, is convenient for clinical use, the process is sable, and the anti-tumor Chinese medicine is suitable for industrial production.
Owner:李红恩

Plaster for curing the protrusion of lumbar intervertebral discs, hyperosteogeny and rheumatoid and preparation method thereof

A plaster for treating lumbar intervertebral disc protrusion, hyperosteogeny and rheumatoid diseases is provided. The plaster contains a base drug prepared from four groups of drugs and a dusted powder drug. The base drug is prepared from rosin and mung bean; sesame oil, angelica, cochinchina momordica seed, common anemarrhena, dahurian angelica root, croton, hard clam, indian iphigenia bulb, corymbose knoxia and teasel root; frankincense, myrrh, dragon's blood, catechu, calomel, verdigris, realgar, salammoniac, arsenic trioxide, gamboge, natural indigo, mercuric oxide, calcined plaster, camphor, kansui root and borneol; and castor seed, almond, hydnocapus seed, cochinchina momordica seed and croton. The dusted powder drug is prepared from ephedra root, Chinese wild ginger, cinnamon, honey locust, raw pinellia tuber, cloven, raw arisaema and borneol. The plaster has the advantages of precise and scientifi formulation, wide raw material source, simple process, low cost, good skin permeation for the affected part, good therapeutic effect, short treatment period and quick effect, and is used for treating lumbar intervertebral disc protrusion, hyperosteogeny and rheumatoid diseases with a cure rate of 63% or higher and a total effective rate of 96% or higher.
Owner:姜学敏

Chinese herbal compound preparation for treating pains and inhibited joint mobility caused by wind and chill pathogenic factors attacking human body as well as preparation method and application of Chinese herbal compound preparation

The invention discloses a Chinese herbal compound preparation. The Chinese herbal compound preparation is prepared from rabdosia megathyrsa, osmorhiza aristata, stems and leaves of woody hawksbeard, Chinese tamarisk twigs, twigs of Germany falsetamarisk, bark of hollowed wampee, root of citrusleaf glycosmis, scorzonera albicaulis bunge, chloranthus japonicus siebold, herb of ternateleaf tabdosia, greater selaginella, callicarpa longissima, leaves of sabina chinensis, root of Chinese wingleaf prickyash, stems and leaves of wild spikenard, lemongrass herb, micromelum integerrimum, leaves of Hongkong kumquat, stems of anderson ironweed and baical skullcap root. The Chinese herbal compound preparation is scientific and reasonable in proportion of medicines, and prescription is strict. An experiment result shows that the Chinese herbal compound preparation has good effects of wind dispelling, palsy relief, cold dispelling, pain relief, swelling and dampness elimination, blood stasis dissipating, meridian dredging, muscle relaxation, promotion of blood circulation and the like, can effectively treat joint function disturbance and has a good treatment effect on pains and inhibited joint mobility as well as stomachache, cough, headache and the like caused by the wind and chill pathogenic factors attacking the human body; the clinical cure rate is high, no remarkable adverse reactions are caused, and the medication safety is good.
Owner:HEILONGJIANG UNIV OF CHINESE MEDICINE

Chinese medicinal compound for treating coronary heart diseases, preparation method and application thereof

The invention discloses a Chinese medicinal compound for treating coronary heart diseases, a preparation method and application thereof. The Chinese medicinal compound consists of the following raw materials in part by weight: 6 to 60 parts of dwarf lilyturf tuber, 3 to 15 parts of common macrocarpium fruit, 3 to 20 parts of leech, 6 to 60 parts of rhodiola rosea, 6 to 60 parts of ginkgo leaf and6 to 60 parts of giant knotweed rhizome. The Chinese medicinal compound provided by the invention is prepared in proportion by adopting the theory of syndrome differentiation and treatment according to the theory of the traditional Chinese medical science, pharmacological experimental results indicate that the Chinese medicinal compound provided by the invention has the excellent effects of nourishing heart and kidney, clearing heat and invigorating blood circulation and eliminating blood stasis and removing obstruction in channels, and the modern pharmacological study indicates that the Chinese medicinal compound has the strong effects of improving myocardial oxygen-carrying capacity, expanding the coronary artery, anticoagulating, resisting inflammation, reducing lipid and the like, so the Chinese medicinal compound can resist myocardial ischemia, relieve angina of the coronary heart diseases, resist arteriosclerosis and prevent thrombosis; and the Chinese medicinal compound provided by the invention has low adverse reactions and can be used for treating the coronary heart diseases.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

A traditional Chinese medicine compound composition for treating pneumoconiosis and pulmonary fibrosis and its preparation method

The invention discloses a Chinese medicine compound composition for treating pneumoconiosis and pulmonary fibrosis and a preparation method thereof. The Chinese medicine compound composition consists of 8-30 parts of Rhodiola rosea, 1-4 parts of Manjing ointment, 2-2 parts of Cordyceps sinensis 6 parts, 1~4 parts of Ganoderma lucidum, 1~4 parts of Strawberry (Oriental), 5~20 parts of Fritillaria, 3~10 parts of Snow Lotus, 1~4 parts of Aster, 3~10 parts of Arzhong, 1 part of Tibetan Comfrey ~4 servings made. The results show that the traditional Chinese medicine compound composition for treating pneumoconiosis and pulmonary fibrosis provided by the present invention has rigorous medication, scientific and reasonable proportioning, has the functions of invigorating lung qi, improving immune function, resolving phlegm and dispelling stagnation, relieving cough and asthma, and improving lung function. Ventilation function and other functions have a strong effect on the respiratory system such as bronchitis, obstructive emphysema, pneumoconiosis, etc., and have high safety and low side effects. At the same time, the preparation method provided by the invention has stable quality, high content of extracted active ingredients, strong operability, and is suitable for large-scale industrial production.
Owner:LIUYANG LIMEI IMMUNITY REHABILITATION CENT CO LTD

A traditional Chinese medicine compound composition with the effect of treating hypertension and diabetes mellitus and its preparation method and application

The invention discloses a traditional Chinese medicine compound composition capable of treating hypertensive patients with diabetes as well as a preparation method and application thereof. The traditional Chinese medicine compound composition is prepared from 15-45 parts of codonopsis pilosula, 15-45 parts of rehmannia root, 10-30 parts of danshen root, 10-30 parts of sophora flower bud, 10-30 parts of common lophatherum herb, 10-30 parts of reed rhizome, 10-30 parts of kudzuvine root, and 10-30 parts of perilla seed. The traditional Chinese medicine compound composition provided by the invention adopts a theory of treatment according to syndrome differentiation to have a prescription, and clinical experimental results show that the traditional Chinese medicine compound composition provided by the invention has comprehensive effects of multiple links and multiple targets, can improve clinical symptoms of hypertensive patients with diabetes, has the effects of lowering blood pressure and blood sugar and improving insulin resistance, and can be used for preventing and treating the hypertensive patients with diabetes; and the clinical experimental results show that the traditional Chinese medicine compound provided by the invention has no adverse reaction after long-term use and is safer to use.
Owner:严士海
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products